Diltiazem - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:55:27Z

Switch SMW query from broadtable to table format for better layout with TOC

← Older revision		Revision as of 21:55, 20 March 2026
Line 95:		Line 95:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T17:24:12Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

← Older revision		Revision as of 17:24, 20 March 2026
Line 97:		Line 97:
	\|format=broadtable		\|format=broadtable
	\|headers=plain		\|headers=plain
	\|~~link~~=~~subject~~		\|mainlabel=-
	\|sort=Has Indication		\|sort=Has Indication
	\|limit=50		\|limit=50

Danbot: Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

2026-03-20T16:42:20Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

← Older revision		Revision as of 16:42, 20 March 2026
Line 84:		Line 84:

	==Comments==		==Comments==


			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Diltiazem]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|link=subject
			\|sort=Has Indication
			\|limit=50
			}}

	==See Also==		==See Also==

Rossdonaldson1: /* Adult Dosing */

2022-09-07T16:45:09Z

Adult Dosing

← Older revision		Revision as of 16:45, 7 September 2022
Line 8:		Line 8:

	==Adult Dosing==		==Adult Dosing==
	===[[Atrial fibrillation with rapid ventricular response~~]] or [[Supraventricular tachycardia~~]] (if hemodynamically stable)===		===[[Atrial fibrillation with rapid ventricular response]] (if hemodynamically stable)===
	*Loading dose = 0.25 mg/kg (max=20 mg) IV bolus over 2 minutes		*Loading dose = 0.25 mg/kg (max=20 mg) IV bolus over 2 minutes
	**Can consider breaking down into 10 mg boluses in older patients to decrease risk of adverse reactions		**Can consider breaking down into 10 mg boluses in older patients to decrease risk of adverse reactions
Line 14:		Line 14:
	**If effective: Start infusion at 5-15 mg/hr		**If effective: Start infusion at 5-15 mg/hr
	***Consider 30mg IR PO or home dose to avoid need for a drip		***Consider 30mg IR PO or home dose to avoid need for a drip

			===[[Supraventricular tachycardia]] (if hemodynamically stable)===
			*Same as for atrial fibrillation with rapid ventricular response (see above)

	==Pediatric Dosing==		==Pediatric Dosing==

Rossdonaldson1 at 16:43, 7 September 2022

2022-09-07T16:43:52Z

← Older revision		Revision as of 16:43, 7 September 2022
Line 6:		Line 6:
	*Routes of Administration: IV, PO		*Routes of Administration: IV, PO
	*Common Trade Names: Cardizem		*Common Trade Names: Cardizem

	~~==Indications==~~
	*[[Atrial fibrillation with rapid ventricular response]] (if hemodynamically stable)
	*[[Supraventricular tachycardia]] (if hemodynamically stable)

	==Adult Dosing==		==Adult Dosing==
			===[[Atrial fibrillation with rapid ventricular response]] or [[Supraventricular tachycardia]] (if hemodynamically stable)===
	*Loading dose = 0.25 mg/kg (max=20 mg) IV bolus over 2 minutes		*Loading dose = 0.25 mg/kg (max=20 mg) IV bolus over 2 minutes
	**Can consider breaking down into 10 mg boluses in older patients to decrease risk of adverse reactions		**Can consider breaking down into 10 mg boluses in older patients to decrease risk of adverse reactions
Line 23:		Line 20:

	==Special Populations==		==Special Populations==
			===[[Drug pregnancy categories\|Pregnancy Rating]]===
	* Pregnancy Rating: C		* Pregnancy Rating: C

			===Lactation risk===
	* Lactation: Does appear to diffuse into breast milk, but doses are typically not harmful to infants		* Lactation: Does appear to diffuse into breast milk, but doses are typically not harmful to infants
	* Renal Dosing: Not studied, use caution
	* Hepatic Dosing: Not studied, use caution		===Renal Dosing===
			*Adult: Not studied, use caution
			*Pediatric: Not studied, use caution

			===Hepatic Dosing===
			*Adult: Not studied, use caution
			*Pediatric: Not studied, use caution

	==Contraindications==		==Contraindications==
	*Allergy to drug/class		*[[Allergy]] to drug/class
	*Infants <1yo		*Infants <1yo
	*Wide-complex tachycardia due to bypass tract (e.g. WPW)		*[[Wide-complex tachycardia]] due to bypass tract (e.g. WPW)
	*Symptomatic severe hypotension		*Symptomatic severe hypotension
	*Sick sinus syndrome/2nd or 3rd degree heart block if no pacemaker		*[[Sick sinus syndrome]]/2nd or 3rd degree heart block if no pacemaker
	*PO: acute MI and pulmonary congestion		*PO: acute [[MI]] and pulmonary congestion
	*Ventricular tachycardia		*[[Ventricular tachycardia]]
	*Caution if:		*Caution if:
	**Hypertrophic cardiomyopathy		**Hypertrophic cardiomyopathy
Line 73:		Line 79:
	*Class IV - Inhibits Ca influx		*Class IV - Inhibits Ca influx
	**Slows AV nodal conduction		**Slows AV nodal conduction

			==Comments==

	==See Also==		==See Also==
Line 78:		Line 86:
	*[[Calcium Channel Blocker Toxicity]]		*[[Calcium Channel Blocker Toxicity]]
	*[[Atrial Fibrillation with RVR]]		*[[Atrial Fibrillation with RVR]]

			==References==
			<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
	[[Category:Cardiology]]		[[Category:Cardiology]]

Athorne: /* Adult Dosing */

2022-08-10T20:54:11Z

Adult Dosing

← Older revision		Revision as of 20:54, 10 August 2022
Line 16:		Line 16:
	**If ineffective after 15 minutes: 0.35mg/kg (max=25mg) over 2 minutes		**If ineffective after 15 minutes: 0.35mg/kg (max=25mg) over 2 minutes
	**If effective: Start infusion at 5-15 mg/hr		**If effective: Start infusion at 5-15 mg/hr
			***Consider 30mg IR PO or home dose to avoid need for a drip

	==Pediatric Dosing==		==Pediatric Dosing==

Rossdonaldson1 at 18:38, 12 May 2022

2022-05-12T18:38:07Z

← Older revision		Revision as of 18:38, 12 May 2022
Line 8:		Line 8:

	==Indications==		==Indications==
	*Atrial fibrillation with rapid ventricular response (if hemodynamically stable)		*[[Atrial fibrillation with rapid ventricular response]] (if hemodynamically stable)
	*Supraventricular tachycardia (if hemodynamically stable)		*[[Supraventricular tachycardia]] (if hemodynamically stable)

	==Adult Dosing==		==Adult Dosing==

Masoodrm: /* Special Populations */

2022-04-30T15:06:42Z

Special Populations

← Older revision		Revision as of 15:06, 30 April 2022
Line 23:		Line 23:
	==Special Populations==		==Special Populations==
	* Pregnancy Rating: C		* Pregnancy Rating: C
	* Lactation:		* Lactation: Does appear to diffuse into breast milk, but doses are typically not harmful to infants
	* Renal Dosing: Not studied, use caution		* Renal Dosing: Not studied, use caution
	* Hepatic Dosing: Not studied, use caution		* Hepatic Dosing: Not studied, use caution

Masoodrm: /* Adult Dosing */

2022-04-30T15:04:28Z

Adult Dosing

← Older revision		Revision as of 15:04, 30 April 2022
Line 12:		Line 12:

	==Adult Dosing==		==Adult Dosing==
	*Loading dose = 0.~~25mg~~/kg (max=~~20mg~~) IV bolus over ~~2min~~		*Loading dose = 0.25 mg/kg (max=20 mg) IV bolus over 2 minutes
	**If ineffective after ~~15min~~: 0.35mg/kg (max=25mg) over ~~2min~~		**Can consider breaking down into 10 mg boluses in older patients to decrease risk of adverse reactions
	**If effective: Start infusion at 5-~~15mg~~/hr		**If ineffective after 15 minutes: 0.35mg/kg (max=25mg) over 2 minutes
			**If effective: Start infusion at 5-15 mg/hr

	==Pediatric Dosing==		==Pediatric Dosing==

Masoodrm: /* Indications */

2022-04-30T15:03:00Z

Indications

← Older revision		Revision as of 15:03, 30 April 2022
Line 8:		Line 8:

	==Indications==		==Indications==
	*~~Conversion of [[PSVT]] to NSR~~		*Atrial fibrillation with rapid ventricular response (if hemodynamically stable)
	*~~Slow RVR in [[a-fib]]/[[Atrial flutter\|flutter]]~~		*Supraventricular tachycardia (if hemodynamically stable)

	==Adult Dosing==		==Adult Dosing==